BUREK JULIE (Vice President, Finance) sold 6.7% of their position (3.33K shares) of VOYAGER THERAPEUTICS, INC. on the open market
Open‑market sale worth $9.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/14/2022ACC: 0001104659-22-004515
Officer· Vice President, Finance
Since Nov 2021
-265.00
Net shares
Net seller
$9.5K
Total sold
2
Open market trades
0B · 2S
3
Total transactions
3.06K acquired · 3.33K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+3.06K
Price / share
$2.30
Trade value
$7.04K
% of position
6.6%
12/31/2021
46.52K→49.59K
Common Stock
Direct
Shares
−3.06K
Price / share
$2.83
Trade value
$8.67K
% of position
6.2%
1/3/2022
49.59K→46.52K
Common Stock
Direct
Shares
−265.00
Price / share
$3.06
Trade value
$810.90
% of position
0.6%
1/12/2022
46.52K→46.26K
Total
Net shares
−265.00
Net value
-$2.43K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/31/2021 | A · Award | +3.06K | $2.30 | $7.04K | 6.6% | 46.52K | 49.59K |
| Common Stock Direct | 1/3/2022 | S · Sale | −3.06K | $2.83 | $8.67K | 6.2% | 49.59K | 46.52K |
| Common Stock Direct | 1/12/2022 | S · Sale | −265.00 | $3.06 | $810.90 | 0.6% | 46.52K | 46.26K |
| Total | −265.00 | -$2.43K | ||||||
Derivative Transactions0
No derivative transactions reported